The role of adjuvants in the development of mucosal vaccines
- 1 July 2005
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Biological Therapy
- Vol. 5 (7) , 953-965
- https://doi.org/10.1517/14712598.5.7.953
Abstract
It is well-established that most pathogens that cause infectious diseases enter the host via mucosal membranes of the respiratory, digestive and genital tracts. Some parenterally administered vaccines induce protection against mucosal pathogens. However, there is increasing evidence that mucosal protection is better afforded by mucosal vaccination, particularly for the induction of memory responses. Mucosal vaccines must pass several difficult hurdles before entering the host and inducing an effective and protective immune response. This review deals with present and past efforts in devising effective mucosal vaccines using delivery systems and immunopotentiating adjuvants for protein-based vaccines. The paper will conclude with the authors’ opinion on how the field will or should progress in the future and what will be the required components of ideal future mucosal vaccines that can induce immunological memory.Keywords
This publication has 107 references indexed in Scilit:
- Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA deliveryAdvanced Drug Delivery Reviews, 2005
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Localization of Distinct Peyer's Patch Dendritic Cell Subsets and Their Recruitment by Chemokines Macrophage Inflammatory Protein (Mip)-3α, Mip-3β, and Secondary Lymphoid Organ ChemokineThe Journal of Experimental Medicine, 2000
- Regional specialization in the mucosal immune system: what happens in the microcompartments?Immunology Today, 1999
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Biodegradable Microspheres in Drug DeliveryCritical Reviews in Therapeutic Drug Carrier Systems, 1995
- Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigensBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1992
- Bacterial cell wall products as adjuvants: early interferon gamma as a marker for adjuvants that enhance protective immunityResearch in Immunology, 1992
- Immunological adjuvants: a role for liposomesImmunology Today, 1990
- CpG islands as gene markers in the vertebrate nucleusTrends in Genetics, 1987